ERBB2 and in situ carcinoma: The diffuse pattern (namely, a focal or diffuse HER2 expression in deeper cell layers) was observed with increasing frequency in mild-to-moderate dysplasia (8/22, 36%) and CIS (12/22, 55%), thus suggesting that HER2 may play a role in malignant transformation.